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Summary: The concentrations of total cholesterol, phospholipids, triacylglycerols and lipoproteins were
measured in 87 follicular fluids obtained from 35 women undergoing in vitro fertilization and embryo transfer.
The results were correlated with the levels of progesterone in follicular fluid. Two different types of ovarian
stimulation were used. High density lipoproteins were the dominant lipoproteins found in the preovulatory
follicular fluid. Low density lipoproteins were absent or appeared in trace amounts. Significantly higher
triacylglycerol and high density lipoprotein levels were found when stimulation with human menopausal
gonadotropins and chorionic gonadotrppin was applied, as compared to the clomiphene citrate-menopausal
gonadotropin-chorionic gonadotropin menstrual cycle. In both groups, extracorporal fertilization resulted in
cleavage of oocytes and embryo transfer. No significant correlation between any follicular fluid lipid and
progesterone concentration was found. The lipids estimated in the follicular fluid appeared to have no
influence on the oocyte fertilizability. The presence of triacylglycerols and high density lipoproteins in the
follicular fluid may indicate follicular wall permeability under the treatment with menopausal gonadotropins.
Introduction progesterone and oestrogens within the follicle. At
The human preovulatory oocyte microenvironment this stage, the biochemical composition of follicular
undergoes profound changes shortly before ovulation. fluid reflects the degree of follicular maturation.
Between 25 and 36 hours after the onset of the lu-
teinizing hormone surge or human chorionic gonado- In the ovary> progesterone is synthesized from cho-
tropin administration, the oocyte maturation pro- iestero1 which may be derived from anV of three
ceeds from prophase I to metaphase ΪΙ stage. Effective sources: de novo synthesis from 2-carbon units, mo-
amounts of luteinizing hormone enter the follicular bilization of intracellularly stored cholesterol ester, or
fluid simultaneously with the emergence of a pre- uptake from extracellular lipoproteins.
ovulatory peak of luteinizing hormone in plasma.
 chole$terol derfved from lipoprotein has been re-
Entry of luteimzmg hormone into the follicle stimu-
 d to ^  of ^ ^ . tance for steroid
lates the resumption of granulosa cdl luteinization.
 d and ^  d iipoproteins appear to be
As a consequence of a vigorous steroidogenesis in the ., ' . . . r u ι * ι · *u u
*. „· t , . . 7 J t . the most important source of cholesterol in the humanpreovulatory follicle, ovulation is preceded by an in-
 n ^/· t ' r«« · ** ovary \^, jj·
crease of plasma progesterone. The concentration of
progesterone in the follicular fluid increases, while Addition of low density lipoproteins, but not high
oestradiol and androstenedione concentrations de- density lipoproteins, to human granulosa cells cul-
cline (1). Gramilosa cells may be the main source of tured in a lipoprotein-free medium in the presence of
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gonadotropins, resulted in a dose-dependent increase
in the production of progesterone (3). Human corpus
luteum and cultured granulosa cells possess a specific
receptor-mediated mechanism for the uptake of low
density lipoproteins and for the utilization of low
density lipoproteins, preferentially as a source of cho-
lesterol substrate (4). In contrast, it was shown by
Simpson et al. (5) that the follicular fluid of human
ovaries at various stages of the normal menstrual cycle
contained little or no low density lipoproteins or very
low density lipoproteins, while the concentration of
high density lipoproteins approached that found in
plasma. It was suggested that the lack of biosynthetic
substrate was the main reason for the limited proges-
terone production on preovulatory follicles.
In view of the crucial role of cholesterol in ovarian
steroidogenesis, a study was undertaken to evaluate
the possibility of considering lipids and lipoproteins
as markers of follicular maturation. The concentra-
tions of cholesterol, phospholipids, triacylglycerols
and lipoproteins in the follicular fluid were correlated
with the concentration of follicular fluid progesterone,
as well as with the fertilization of oocytes derived
from cycles stimulated by two types of ovarian in-
duction for in vitro fertilization.
Materials and Methods
Patients and treatment
Preovulatory follicular fluids were obtained from 35 women,
who where infertile due to tubal absence, and expected to
undergo extracorporal fertilization and embryo transfer. They
were aged 24—38 years and had regular menstrual cycles
(30 ± 4 days).
To stimulate follicular growth, clomiphene citrate (Clomiphene,
Richardson-Merrell-Belupo, Yugoslavia) was given to 26
women during 5 days, in a dose of 100 mg daily, starting from
the fourth or fifth day of the menstrual cycle. On the last day
of clomiphene administration, ovulation was induced with hu-
man menopausal gonadotropins (Pergonal, Serono, W. Ger-
many). The dose varied depending on the growth of dominant
follicles and on the daily rise in serum oestradiol. When the
two largest follicles measured by ultrasound (Toshiba Real Time
Scanner, Japan) were at least 16 mm in diameter and serum
oestradiol concentrations were above 1.4 nmol/1 per follicle,
5000 IU of chorionic gonadotropin (Pregnyl, Organon, Hol-
land) were given. Laparoscopic aspiration of the follicles was
performed 34—36 h later.
In 9 patients, follicular growth was induced with 150 IU of
menopausal gonadotropins on the third and fourth day of the
cycle. Thereafter, the dose of menopausal gonadotropins was
gradually increased, depending on the individual response. Cho-
rionic gonadotropin was given intramuscularly 34—36 h before
laparoscopy and oocyte retrieval, in a dose of 10000 IU.
In vitro fertilization
All specimens were microscopically examined, the oocyte-cor-
ona-cumulus complexes identified, and a culture set up in a
modified HAM's F-10 medium (Seromed, W. Germany) at
37 °C in a humidified atmosphere of 5% CO2, 5% O2 and 90%
N2 (Heraeus, W. Germany). The insemination medium was
supplemented with 10% newborn heat-inactivated cord serum
(30 min at 55 °C). Oocyte-corona-cumulus complexes were
preincubated for 4—6 h before introducing the sperm prepared
by washing twice with the insemination medium. The sperma-
tozoa were then isolated by centrifugaftion (300 g for 10 min)
and resuspended in the medium. To each culture of oocyte^
corona-cumulus complex, 0.33 ±0.18 χ ΙΟ6 of motile sperm
was added. Eighteen hours after insemination, mechanically
denuded oocytes were moved to the growth medium enriched
with 20% serum. The culture was continued for an additional
24 h.
Follicular fluids were centrifuged at 1000 g and the cell-free
liquid stored at —20 °C pending assay. Any blood^contami-
nated samples (determined with the Haemoglobinometer, Coul-
ter Electronics Ltd., UK) were discarded. Sixty two samples
from clomiphene-menopausal gonadotropin and 25 from meno-
pausal gonadotropin cycles were analysed.
Lipid, lipoprotein and hormone assays
Total cholesterol (7), total phospholipids (8) and triacylglycerols
in follicular fluid were assayed by enzymatic methods (Bio^
Merieux, France; Code Nos. 61224, 61491 and 61236, respec-r
tively). LDLs were precipitated by polycondensed polycyclic
anionic surface-active agents in imidazole buffer (BioMerieux,
France; Code No. 61532), and the separation of HDLs was
performed by polyethylene glycol precipitation (10) from fol-
licular fluid (Immimo AG, Austria; Code No. 8251015). These
fractions were analysed for bound cholesterol.
The lipid content of follicular fluid is expressed as the concen-
tration of lipids in l g of total proteins. Protein was estimated
using the Polin phenol reagent according to the method of
Lowry et al. (11).
Serum oestradiol and follicular fluid progesterone concentra-
tions were measured by radioimmunoassay using a direct tech^
nique (12). Reagents were from Biodata Laboratories (Italy).·
As the concentration of progesterone in human follicular fluid
is known to be high, the samples were diluted 1:1000 prior to
assaying with 0.01 mol/1 phosphate buffer (pH, 7.5). As diluted
samples and standard preparations give parallel plots for the
displacement of radiolabelled steroid (13), follicular fluids were
not extracted with the solvent before the assay.
Between-run precision studies yielded variation coefficients of
9% for serum oestradiol, 12% for follicular fluid progesterone,
and 5% — 11 % for the concentrations of lipids and lipoproteins.
The results are expressed as mean ± SD values. Statistical
analysis of follicular fluid lipid, lipoprotein and progesterone
concentrations, differences among the groups according to the
type of follicular growth induction, and the result of in vitro
fertilization were calculated by Kruskal-Wallis one-way
ANOVA (14). The correlation between follicular fluid lipids
and progesterone concentration is expressed as a Spearman
rank correlation coefficient, with p values below 0.05 considered
to be significant.
Results
In 47 (75.8%) out of 62 follicular fluids of clomi-
phene-gonadotropin cycles, the oocytes'obtained were
found to have been fertilized and undergone cleavage.
The remaining 15 (24.2%) oocytes were not fertilized.
In the cycles stimulated with menopausal gpnadotro-
pins, only 19 fluids yielded fertili^ble oocytes (76%),
while in 6 (24%) cycles fertilization failed.
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Tab. 1. Follicular fluid concentrations of lipids, HDL-cholcstcrol and progesterone (mean ± SD), depending on the type of
ovarian induction and the result of in vitro fertilization.
Type of ovarian induction/
Result of in vitro fertilization
Cholesterol Phospholipids Triacyl- HDL- Progesterone
(μπιοΐ/g total (μιηοΐ/g total glyccrols cholesterol (nmol/g total
proteins) proteins (μΐΏθΙ/g total (μηιοΐ/g total proteins)
proteins) proteins)
1 . Clomiphene-gonadotropins,
fertilization (n = 47)
2. Clomiphene-gonadotropins,
no fertilization (n = 1 5)
3. Gonadotropins,
fertilization (n = 19)
4. Gonadotropins,
no fertilization (n = 6)
Significance
13.1 ± 2.8
15.3 ± 8.6
17.9 ± 9.9
15.1 ± 6.2
N.S.
19.5 ± 3.8
19.7 ± 3.8
24.7 ± 13.5
19.6 ± 5.6
N.S.
7.3 ± 3.5
6.1 ± 1.8
9.8 ± 4.2*
6.1 ± 1.9
* p < 0.05
3.9 ± 1.2
4.3 ± 1.4
7.5 ± 3.2**
4.9 ± 1.9
** p < 0.005
432.5 ± 376.4
337.7 ± 258.2
276.9 ±171.2
210.3 ± 127.2
N.S.
Data for the concentrations oflipids, lipoproteins and
progesterone in follicular fluid are shown in table 1.
The difference between the follicular fluid triacylgly-
cerols in clomiphene-gonadotropin and in gonadotro-
pin-only cycles was found to be significant (p < 0.05).
Low density lipoproteins in the follicular fluid were
either not found or appeared in trace amounts. The
precipitation technique used for lipoprotein determi-
nation was checked by ultracentrifugation and cello-
gel electrophoresis. We could not find any significant
difference by measuring lipoproteins using the precip-
itation method. The concentration of high density
lipoprotein cholesterol found in the follicular fluid
from clomiphene-gonadotropin cycles represented
31.7% ± 9.2% of total cholesterol measured. A sig-
nificantly elevated (p < 0.005) high density lipopro-
tein concentration was detected in gonadotropin-fer-
tilization cycles. The high density lipoprotein choles-
terol concentration in all fluids from gonadotropin-
only cycles was 27.1% ± 9.3% of the total cholesterol
amount. The concentration of progesterone in pre-
ovulatory follicular fluid did not differ significantly
among the groups studied. Higher values were ob-
served in all clomiphene-gonadotropin fluids (405.5
± 349.2 nmol/g total proteins) as compared with all
gonadotropin-only fluids (260.3 ± 161.4 nmol/g total
proteins), but the difference was not significant. No
significant correlation was recorded between any fol-
licular fluid lipid and progesterone concentrations. A
negative insignificant correlation (Spearman rank cor-
relation coefficient: — 0.136, p > 0.05) was found be-
tween the high density lipoprotein cholesterol and
progesterone concentrations in the follicular fluids
from both types of ovarian induction when oocytes
were fertilized in vitro.
Discussion
Luteinizing granulosa cells are a primary source of
progesterone secreted by the ovulatory follicle (15).
The studies of Hillicr & Wickings (16) have shown
that both the production of progesterone in granulosa
cells and the concentration of follicular fluid proges-
terone increase as the follicle approaches ovulation.
Between the starting moment of the luteinizing hor-
mone surge and that of the follicular rupture, the
progesterone-producing capacity of luteinizing granu-
losa cells increases more than a hundred times.
A critical role of cholesterol in steroidogenesis within
the follicle has been proposed by Berger et al. (17).
They found a direct linear correlation among choles-
terol, oestradiol and progesterone in follicular fluid.
However, these findings could not be confirmed by
our experiment. Higher, but not statistically signifi-
cantly, concentrations of cholesterol in the follicular
fluid in gonadotropin induction when extracorporal
fertilization was successful, could be the result of
permeability changes within the follicle under the
influence of gonadotropins. Higher doses of gonado-
tropins given in gonadotropin cycles as compared to
clomiphene-gonadotropin cycles may be responsible
for molecular sieve changes of the blood-follicle bar-
rier, facilitating the passage of lipids in an inverse
proportion to the molecular weight and size. Such an
explanation was originally proposed by Shalgi et al.
(18) for follicular fluid proteins.
Our study has demonstrated that about 30% of the
lipids are recovered in the high density lipoprotein
fraction. Low density lipoproteins were absent from
the follicular fluid or present in trace amounts only,
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which is in agreement with previous observations (5,
17, 19). The transport form of the majority of the
remaining lipids in follicular fluid is unknown. It has
been suggested that the very low levels of low density
lipoproteins in preovulatory follicle are responsible
for the low progesterone production (5). However,
this is negated by the high levels of progesterone found
in follicular fluid (1, 11, 17, 20). When the plasma
progesterone level reaches its maximum during the
mid-luteal phase, the corpus luteum secretes more
than 7.8 nmol of progesterone per day (16). Since this
rate of production is too high to be sustained by
steroid synthesized from endogenous cholesterol, an
exogenous source must also be introduced. Granu-
losa-lutein cells, like many other cells, can derive
unesterified cholesterol from the uptake and degra-
dation of low density lipoproteins (3). The uptake can
be stimulated by chorionic gonadotropin and requires
interaction of low density lipoproteins with specific
receptors in the cell membrane (2). Cholesteryl esters
of low density lipoproteins are hydrolysed by the
action of cholesteryl esterase1), which in turn, is in-
creased in response to luteinizing hormone action.
Thus liberated cholesterol is available for progeste-
rone biosynthesis.
Follicular fluid contains high density lipoproteins at
a concentration approximately half that in serum.
High density lipoproteins may be consumed to pro-
vide cholesterol within the preovulatory follicle by the
mechanism described by Enk et al. (21). Recently,
they have shown that human granulosa cells can
utilize cholesterol carried by high density lipoproteins
as well as low density lipoproteins for progesterone
synthesis in vitro. The identification of specific high-
affinity high density lipoprotein-receptor sites in hu-
man corpus luteum membranes (22) suggests that a
receptor-mediated high density lipoprotein pathway
may exist in human steroidogenic tissues. The func-
tional characteristics of high density lipoprotein re-
ceptors have so far not been delineated in humans.
Using the whole high density lipoprotein fraction, the
enhancing effect on progesterone production found
in the study of Enk et al. (21) might be due to a
') Enzyme: Cholesteryl esterase (EC 3.1.1.13)
higher relative cholesterol content. The saturable pro-
gesterone response is indicative of a receptor-mediated
cholesterol uptake.
The presence of high density iipoproteins is related to
the high steroidogenic activity of the follicle cells.
After ovulatiou, changes in follicular vascularization
permit the low density lipoprotein-granulosa cell in-
teractions and, thus, the acquisition of cholesterol
from low density lipoproteins, high density lipopro-
teins, or both. In the present study, a strict relation-
ship between the follicular fluid high density lipopro-
tein and progesterone concentrations was not found.
Hypothetically, because of a negative correlation
tendency, liquids with high progesterone may contain
low concentrations of high density lipoproteins, sug-
gesting the consumption of these lipoproteins as a
source of cholesterol.
The phospholipid and triacylglycerol concentrations
in follicular fluid found in our study were about 30%
and 20% of the corresponding values in serum, re-
spectively. The origin of triacylglycerols in the folli-
cular fluid is unknown. Significant differences in the
triacylglycerol contents after two different modes of
ovarian stimulation may have resulted from microen-
vironmental changes within the preovulatory follicle.
The absence of any differences in the lipid content
between the follicular fluids obtained from unferti-
lized and fertilized samples suggest that the lipids
taken into consideration seem to be of no significance
in the ability of oocyte to be successfully fertilized in
vitro.
More appropriate experimental arrangements, such
as granulosa cell culture experiments using labelled
precursors, should be used to obtain clear conclusions
on the source of cholesterol for the synthesis of pro-
gesterone.
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